Citalopram for Sx/Util in Acute Coronary Syndrome Patients



Status:Withdrawn
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:January 2018
End Date:February 2021

Use our guide to learn which trials are right for you!

Symptoms (chest pain, shortness of breath, dizziness, etc.) and treatment usage (doctor or
emergency room visits, testing, hospital days, etc.) in patients with Acute Coronary
Syndromes are known to be related to emotional distress (Anxiety, Depression and Anger). In
addition, behavioral treatment of emotional distress is known to decrease symptoms, and
treatment usage. The present protocol tests whether the addition of a medication known to
reduce emotional distress can also reduce symptoms and treatment usage.

This will done by recruiting patients with ACS during their hospital stay, randomizing them
to receive citalopram or placebo, and then examining their symptoms and treatment usage at 6
months.

Not applicable. Study not funded.

Inclusion Criteria:

- Admission to hospital for chest pain/dyspnea, typical ECG changes plus positive
tropinins

Exclusion Criteria:

- age less than 18

- cognitive impairment (per MMSE)

- geographic unavailability for followup

- unwillingness to participate

- illiteracy

- Hx cardiac transplant

- untreated hypothyroidism

- hepatic dysfunction

- prior adverse reaction to citalopram

- history of Bipolar Disorder

- untreated Sleep Apnea

- chronic steroid therapy

- active substance abuse (e.g., within past year)

- near term mortal illness

- current mental health treatment

- signitificant suicide risk
We found this trial at
1
site
2799 W Grand Blvd
Detroit, Michigan 48202
(313) 916-2600
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
?
mi
from
Detroit, MI
Click here to add this to my saved trials